JP2007001977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007001977A5 JP2007001977A5 JP2006170554A JP2006170554A JP2007001977A5 JP 2007001977 A5 JP2007001977 A5 JP 2007001977A5 JP 2006170554 A JP2006170554 A JP 2006170554A JP 2006170554 A JP2006170554 A JP 2006170554A JP 2007001977 A5 JP2007001977 A5 JP 2007001977A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- extract
- pharmaceutical composition
- cell line
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 claims 28
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 125000004432 carbon atom Chemical group C* 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 8
- 241000196324 Embryophyta Species 0.000 claims 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 230000006378 damage Effects 0.000 claims 4
- 238000001914 filtration Methods 0.000 claims 4
- 208000033808 peripheral neuropathy Diseases 0.000 claims 4
- 241001519274 Ajuga reptans Species 0.000 claims 3
- 239000002028 Biomass Substances 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000011347 resin Substances 0.000 claims 3
- 229920005989 resin Polymers 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010003645 Atopy Diseases 0.000 claims 2
- 206010012335 Dependence Diseases 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 102000011782 Keratins Human genes 0.000 claims 2
- 108010076876 Keratins Proteins 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 208000026062 Tissue disease Diseases 0.000 claims 2
- 239000008346 aqueous phase Substances 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000002016 disaccharides Chemical class 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 230000002779 inactivation Effects 0.000 claims 2
- 239000002207 metabolite Substances 0.000 claims 2
- 150000002772 monosaccharides Chemical group 0.000 claims 2
- 210000000653 nervous system Anatomy 0.000 claims 2
- 201000001119 neuropathy Diseases 0.000 claims 2
- 230000007823 neuropathy Effects 0.000 claims 2
- 229930015704 phenylpropanoid Natural products 0.000 claims 2
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 claims 2
- 229930010796 primary metabolite Natural products 0.000 claims 2
- 230000000241 respiratory effect Effects 0.000 claims 2
- 229930000044 secondary metabolite Natural products 0.000 claims 2
- 230000009759 skin aging Effects 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 208000020431 spinal cord injury Diseases 0.000 claims 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical group OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 206010002383 Angina Pectoris Diseases 0.000 claims 1
- 206010059245 Angiopathy Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 201000006474 Brain Ischemia Diseases 0.000 claims 1
- 208000002177 Cataract Diseases 0.000 claims 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 claims 1
- 206010008120 Cerebral ischaemia Diseases 0.000 claims 1
- 230000010736 Chelating Activity Effects 0.000 claims 1
- 208000032544 Cicatrix Diseases 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 241000701022 Cytomegalovirus Species 0.000 claims 1
- 206010011831 Cytomegalovirus infection Diseases 0.000 claims 1
- 208000020401 Depressive disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 208000009889 Herpes Simplex Diseases 0.000 claims 1
- 208000007514 Herpes zoster Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 208000029549 Muscle injury Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010029098 Neoplasm skin Diseases 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 201000007737 Retinal degeneration Diseases 0.000 claims 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 208000010641 Tooth disease Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 230000003542 behavioural effect Effects 0.000 claims 1
- 238000004061 bleaching Methods 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 208000029028 brain injury Diseases 0.000 claims 1
- 229940074360 caffeic acid Drugs 0.000 claims 1
- 235000004883 caffeic acid Nutrition 0.000 claims 1
- 206010008118 cerebral infarction Diseases 0.000 claims 1
- 230000007882 cirrhosis Effects 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims 1
- 239000000701 coagulant Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000007887 coronary angioplasty Methods 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 238000010828 elution Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 210000001156 gastric mucosa Anatomy 0.000 claims 1
- 208000007565 gingivitis Diseases 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 230000005484 gravity Effects 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 230000000302 ischemic effect Effects 0.000 claims 1
- 230000000366 juvenile effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 229910021645 metal ion Inorganic materials 0.000 claims 1
- 210000002200 mouth mucosa Anatomy 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 230000014508 negative regulation of coagulation Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 208000028169 periodontal disease Diseases 0.000 claims 1
- 208000027232 peripheral nervous system disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000001782 photodegradation Methods 0.000 claims 1
- 238000006303 photolysis reaction Methods 0.000 claims 1
- 230000015843 photosynthesis, light reaction Effects 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 238000011085 pressure filtration Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000004258 retinal degeneration Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 231100000241 scar Toxicity 0.000 claims 1
- 230000037387 scars Effects 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 1
- 230000001953 sensory effect Effects 0.000 claims 1
- 230000035939 shock Effects 0.000 claims 1
- 230000037380 skin damage Effects 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000000451 tissue damage Effects 0.000 claims 1
- 231100000827 tissue damage Toxicity 0.000 claims 1
- 230000008359 toxicosis Effects 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05425441.2 | 2005-06-20 | ||
| EP05425441 | 2005-06-20 | ||
| EP05425585.6 | 2005-08-08 | ||
| EP05425585.6A EP1736166B2 (en) | 2005-06-20 | 2005-08-08 | Extracts from Ajuga reptans cell lines, their preparation and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013173952A Division JP5788936B2 (ja) | 2005-06-20 | 2013-08-23 | アジュガ・レプタンス細胞株由来の抽出物、その製造及び使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007001977A JP2007001977A (ja) | 2007-01-11 |
| JP2007001977A5 true JP2007001977A5 (2) | 2009-08-06 |
| JP5443664B2 JP5443664B2 (ja) | 2014-03-19 |
Family
ID=37025252
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006170554A Active JP5443664B2 (ja) | 2005-06-20 | 2006-06-20 | アジュガ・レプタンス細胞株由来の抽出物、その製造及び使用 |
| JP2013173952A Active JP5788936B2 (ja) | 2005-06-20 | 2013-08-23 | アジュガ・レプタンス細胞株由来の抽出物、その製造及び使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013173952A Active JP5788936B2 (ja) | 2005-06-20 | 2013-08-23 | アジュガ・レプタンス細胞株由来の抽出物、その製造及び使用 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US9623063B2 (2) |
| EP (2) | EP1997501B1 (2) |
| JP (2) | JP5443664B2 (2) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101526303B1 (ko) * | 2008-03-31 | 2015-06-05 | (주)아모레퍼시픽 | 항노화용 화장료 조성물 |
| EP2319914A1 (en) * | 2009-11-09 | 2011-05-11 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Preparation and use of plant meristem cells with a high content of caffeic acid derivatives |
| EP2340808A1 (en) | 2009-12-21 | 2011-07-06 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Synergic combination of phenylpropanoids, such as verbascoside or teupolioside, and mesalamine |
| IT1400234B1 (it) * | 2010-05-07 | 2013-05-24 | I R B Istituto Di Ricerche Biotecnologiche S R L | Derivati esterei di fenilpropanoidi |
| WO2013156858A1 (en) * | 2012-04-20 | 2013-10-24 | Purapharm Company Limited | Materials and methods for prevention and treatment of viral infections |
| US9289374B2 (en) * | 2014-04-23 | 2016-03-22 | Lifevantage Corporation | Topical compositions and methods for reducing oxidative stress |
| ITUB20159551A1 (it) * | 2015-12-21 | 2017-06-21 | Purytra Farm S P A | Composizione farmaceutica per il trattamento dell?iperplasia prostatica |
| EP3624763B1 (en) * | 2017-05-18 | 2026-04-22 | Medena AG | Use of naturally glycosylated polyphenols as protective agents against the effects of ultraviolet irradiation |
| EP3751002A4 (en) * | 2018-02-06 | 2021-12-01 | Shanghai Dongxi Zhihui Biological Medicine Co., Ltd. | NEW COMPOUND FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASE AND ITS APPLICATION |
| CN108776121B (zh) * | 2018-04-08 | 2021-07-30 | 广州卡马生物科技有限公司 | 一种基于荧光猝灭原理对药材中抗氧剂的高通量筛选方法 |
| EP3817715B1 (fr) * | 2018-07-06 | 2023-05-17 | Laboratoires de Biologie Végétale Yves Rocher | Utilisation cosmetique de hrgp (hydroxyprolin rich glycoproteins) issues de cellules d'ajuga reptans pour prevenir et/ou lutter contre les effets du vieillissement de la peau |
| CN115466248B (zh) * | 2022-02-08 | 2024-10-29 | 厦门稀土材料研究所 | 二萜类化合物及其提取方法和用途 |
| CN115840019B (zh) * | 2022-12-27 | 2025-01-07 | 贵州百灵企业集团制药股份有限公司 | 一种艾纳香药材质量检测方法 |
| IT202300017805A1 (it) * | 2023-08-30 | 2025-03-02 | Idi Integratori Dietetici Italiani S R L | Nuova composizione comprendente teupolioside e inositolo |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3926390A1 (de) * | 1989-08-10 | 1991-02-14 | Bayer Ag | Verwendung von lysozym genen in pflanzen zur resistenzerhoehung |
| JPH07223962A (ja) * | 1994-02-14 | 1995-08-22 | Pola Chem Ind Inc | 血栓抑制剤及びそれを含む組成物 |
| US5882664A (en) * | 1996-08-02 | 1999-03-16 | Institute For Advanced Skin Research, Inc. | Composition for enhancing hyaluronic acid productivity and method for preparing same |
| IT1317732B1 (it) * | 2000-01-20 | 2003-07-15 | Giuliani Spa | Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per |
| JP3448006B2 (ja) * | 2000-03-29 | 2003-09-16 | 独立行政法人食品総合研究所 | 機能性エマルション |
| JP3430132B2 (ja) * | 2000-08-22 | 2003-07-28 | 株式会社東洋新薬 | イネ若葉中のγ−アミノ酪酸含量を高める方法 |
| WO2004033673A2 (en) † | 2002-10-10 | 2004-04-22 | I.R.B. Istituto Di Ricerche Biotecnologiche S.R.L. | Production process for plant biomass and its use |
| US20070207228A1 (en) * | 2004-03-02 | 2007-09-06 | Giammaria Giuliani | Composition for Regulating the Trophism of Hair Follicles and the Cutaneous Production of Sebum and Use Thereof in Androgenic Alopecia |
| ITMI20050498A1 (it) | 2005-03-24 | 2006-09-25 | Giuliani Spa | Composizione a base di estratti vegetali di ajuga reptans per prevenire la caduta dei capelli stimolare la crescita dei capelli regolare la produzione di sebo |
-
2005
- 2005-08-08 EP EP08162332.4A patent/EP1997501B1/en not_active Expired - Lifetime
- 2005-08-08 EP EP05425585.6A patent/EP1736166B2/en not_active Expired - Lifetime
-
2006
- 2006-06-19 US US11/455,505 patent/US9623063B2/en active Active
- 2006-06-20 JP JP2006170554A patent/JP5443664B2/ja active Active
-
2013
- 2013-08-23 JP JP2013173952A patent/JP5788936B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007001977A5 (2) | ||
| DE69611182T2 (de) | Aus einer pflanze von geschlecht commiphora extrajierte produkte, insbesondere aus der pflanze commiphora mukul, und diese enthaltende extrakten sowie deren verwendung in der kosmetik | |
| JP6931930B2 (ja) | 微細藻類からフコキサンチンおよび／またはポリサッカライドを生産するための改善されたプロセス | |
| CN102112106B (zh) | 包含经发酵和酶处理的绿豆种子提取物、用于皮肤抗老化的化妆品组合物 | |
| DE3049773C2 (de) | Verfahren zur Herstellung von Pektin aus Pflanzengeweben | |
| JPH08503122A (ja) | バニラ豆の処理による天然バニラ香料の製造方法及びそれにより得られた香料 | |
| KR101040508B1 (ko) | 녹두 발효-효소 추출액을 포함하는 피부 노화 방지 및 보습용 화장료 조성물 | |
| DE2021465B2 (de) | Verfahren zur Herstellung eines Enzympräparates, welches die OH-Gruppe in der 3beta-Stellung des Cholesterins dehydriert | |
| WO1999033939A1 (en) | Barley malt oil containing vegetable ceramide-associated substances and process for producing the same | |
| JP2000513743A (ja) | イロン類の製造方法 | |
| DE102015011780A1 (de) | Neue Glutaminylcyclase-lnhibitoren | |
| JP2024159808A (ja) | 非誘導脱分化ラバンデュラ・アングスティフォリア（Ｌａｖａｎｄｕｌａ ａｎｇｕｓｔｉｆｏｌｉａ）植物細胞、その抽出物及びその美容的使用 | |
| DE3247610A1 (de) | Verfahren zur herstellung von rosmarinsaeure aus pflanzenzellkulturen und von rosmarinsaeure enthaltenden pflanzenzell-presslingen | |
| JP3806693B2 (ja) | 大豆加工副産物からピニトールを高収率で回収する方法 | |
| BRPI0611316A2 (pt) | processo para a preparacão e isolamento de fosfatìdeos, suas composicões farmacêuticas e respectivos usos | |
| JP2017132694A (ja) | 月下美人のカルス作出方法及び、その抽出物を有効成分とする皮膚外用剤や内用剤など | |
| CN105199852A (zh) | 一种以重庆奉节云烟87花蕾为原料提取精油的工艺及应用 | |
| CN104055701B (zh) | 一种抗敏护发洗发水 | |
| KR102365212B1 (ko) | 바실러스 서브틸리스 균주를 이용한 대두발효물의 제조방법 및 대두발효물의 이취 저감방법 | |
| JPS6036B2 (ja) | ムラサキ科植物の組織培養方法 | |
| US4308350A (en) | Method for producing cacao butter substitute | |
| EP2179047A2 (de) | Zubereitungen, enthaltend myristinsäure, palmitinsäure, squalan und/oder squalen und verfahren zu deren gewinnung aus mikroorganismen | |
| JP2009114146A (ja) | トランスグルタミナーゼ−１産生促進剤及びインボルクリン産生促進剤 | |
| JPS60149393A (ja) | トコフエロ−ルの製造法 | |
| US12329850B2 (en) | Microalgae having high loliolide productivity |